Yokoyama Y - Search Results

1

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.

Yokoyama Y, Xin B, Shigeto T, Mizunuma H. Yokoyama Y, et al. J Cancer Res Clin Oncol. 2011 Aug;137(8):1219-28. doi: 10.1007/s00432-011-0993-1. Epub 2011 Jun 17. J Cancer Res Clin Oncol. 2011. PMID: 21681689

2

Metastatic vulvar Paget's disease responding to combination chemotherapy: case report.

Yokoyama Y, Mabuchi M, Kawabata I, Niwa K, Shimokawa K, Tamaya T. Yokoyama Y, et al. Jpn J Clin Oncol. 1990 Dec;20(4):426-30. Jpn J Clin Oncol. 1990. PMID: 2178199

3

Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer.

Yokoyama Y, Sakamoto T, Sato S, Saito Y. Yokoyama Y, et al. Eur J Gynaecol Oncol. 1999;20(5-6):361-6. Eur J Gynaecol Oncol. 1999. PMID: 10609495

4

Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.

Futagami M, Sato S, Sakamoto T, Yokoyama Y, Saito Y. Futagami M, et al. Among authors: yokoyama y. Gynecol Oncol. 2001 Sep;82(3):544-9. doi: 10.1006/gyno.2001.6330. Gynecol Oncol. 2001. PMID: 11520153

5

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer.

Umemoto M, Yokoyama Y, Sato S, Tsuchida S, Al-Mulla F, Saito Y. Umemoto M, et al. Among authors: yokoyama y. Br J Cancer. 2001 Sep 28;85(7):1032-6. doi: 10.1054/bjoc.2001.2034. Br J Cancer. 2001. PMID: 11592776 Free PMC article.

6

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.

Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Umemoto M, Sakamoto T, Sato S, Mizunuma H, Smith SK. Yokoyama Y, et al. Br J Cancer. 2003 Jan 27;88(2):237-44. doi: 10.1038/sj.bjc.6600701. Br J Cancer. 2003. PMID: 12610509 Free PMC article.

7

Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.

Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK. Yokoyama Y, et al. Clin Cancer Res. 2003 Apr;9(4):1361-9. Clin Cancer Res. 2003. PMID: 12684405

8

A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina.

Yokoyama Y, Sakamoto A, Umemoto M, Futagami M, Sakamoto T, Maruyama H, Sato S, Mizunuma H. Yokoyama Y, et al. Eur J Gynaecol Oncol. 2003;24(5):435-7. Eur J Gynaecol Oncol. 2003. PMID: 14584665

9

Asymptomatic intracardiac metastasis from a low-grade endometrial stromal sarcoma with successful surgical resection.

Yokoyama Y, Ono Y, Sakamoto T, Fukuda I, Mizunuma H. Yokoyama Y, et al. Gynecol Oncol. 2004 Mar;92(3):999-1001. doi: 10.1016/j.ygyno.2003.11.049. Gynecol Oncol. 2004. PMID: 14984976

10

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.

Sakamoto A, Yokoyama Y, Umemoto M, Futagami M, Sakamoto T, Bing X, Mizunuma H. Sakamoto A, et al. Among authors: yokoyama y. Br J Cancer. 2004 Aug 16;91(4):633-8. doi: 10.1038/sj.bjc.6602009. Br J Cancer. 2004. PMID: 15266333 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,709 results

Search Page

Filters